Answers are grounded in this paper and cite their sources.
Clinical practice guideline reveals limited evidence for treatments in immune thrombocytopenia, highlighting shared decision-making to minimize medication side effects.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Neunert et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: